3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia
33
Leukemia, Lymphocytic, Chronic, B-Cell
26
Lymphoma
19
Myelodysplastic Syndromes
16
Hodgkin Disease
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Multiple Myeloma
10
Leukemia, Myeloid, Acute
10
Lymphoma, Non-Hodgkin
8
Lymphoma, Mantle-Cell
7
Lymphoma, Follicular
7
Recurrence
6
Myeloproliferative Disorders
6
Lymphoma, Large B-Cell, Diffuse
6
Leukemia, Myeloid, Chronic-Phase
6
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Hematologic Neoplasms
5
Waldenstrom Macroglobulinemia
4
Neoplasms, Plasma Cell
4
Lymphoma, T-Cell, Cutaneous
4
Congenital Abnormalities
4
Burkitt Lymphoma
4
Anemia, Aplastic
4
Sezary Syndrome
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Myelodysplastic-Myeloproliferative Diseases
3
Mycosis Fungoides
3
Lymphoma, T-Cell, Peripheral
3
Lymphoma, Large-Cell, Immunoblastic
3
Interventions
X-Rays
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Phantoms, Imaging
5
Vincristine
4
Nuclear Medicine Department, Hospital
4
Doxorubicin
4
Dactinomycin
4
Radiotherapy
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
Vemurafenib
2
Radiotherapy, Conformal
2
Radiation
2
LY3023414
2
Etoposide
2
Cyclophosphamide
2
Carboplatin
2
thymoglobulin
1
sargramostim
1
pembrolizumab
1
lorvotuzumab mertansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Wilms Tumor
×
Alemtuzumab
×
Clear all
No trials found.